Not Medicare Enrolled

Dr. Joan Siracuse, MD

Cardiovascular Disease · Sebring, FL
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
2237 US HIGHWAY 27 S, Sebring, FL 33870
8633854300
In practice since 2005 (20 years)
NPI: 1649252925 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Siracuse from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Siracuse? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Siracuse

Dr. Joan Siracuse is a cardiovascular disease in Sebring, FL, with 20 years in practice. Based on federal Medicare data, Dr. Siracuse performed 5,958 Medicare services across 3,409 unique beneficiaries.

Between the years covered by Open Payments, Dr. Siracuse received a total of $6,781 from 31 pharmaceutical and/or device companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Siracuse is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 16% volume in FL$ $6,781 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,958
Medicare services
Top 16% in FL for cardiovascular disease
3,409
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~298 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Regadenoson injection (Lexiscan) for heart stress test1,012$44$89
Electrocardiogram (EKG), 12-lead825$10$25
Technetium tc-99m sestamibi, diagnostic, per study dose724$88$275
Office visit, established patient (20-29 min)565$61$136
Office visit, established patient (30-39 min)450$89$192
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician361$47$113
Nuclear medicine studies of heart muscle at rest and with stress and spect359$328$546
Echocardiogram, transthoracic260$139$285
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec185$25$75
Ultrasound of both sides of head and neck blood flow148$110$230
Remote pacemaker/defibrillator monitoring, 90 days127$16$29
Evaluation of cardiac rhythm monitor system, remote up to 30 days120$18$28
Anticoagulant management of patient taking warfarin87$9$28
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent81$7$25
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days75$18$26
Evaluation of single, dual, multiple lead or leadless pacemaker system73$15$50
Remote pacemaker monitoring, 90 days69$22$33
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days58$27$67
Heart rhythm review and interpretation of continous external ekg over 8-15 days55$20$68
Injection, perflutren lipid microspheres, per ml43$35$182
Programming of dual lead pacemaker system41$26$77
Prothrombin time test (blood clotting)38$4$11
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional33$8$38
Injection of drug or substance into vein26$28$56
Programming of multiple lead implantable defibrillator system25$43$118
Evaluation of single, dual, or multiple lead implantable defibrillator system25$28$84
New patient office visit (45-59 min)25$104$360
Ultrasound of heart, follow-up23$68$123
Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts18$94$182
Ultrasound of leg arteries or artery grafts14$143$182
Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days13$18$62
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.0% high complexity
33.3% medium
53.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,781
Total received (2018-2024)
Avg $969/year across 7 years
Top 32% in FL for cardiovascular disease
31
Companies
362
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,487 (95.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$293 (4.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$512
2023
$1,076
2022
$1,608
2021
$991
2020
$905
2019
$926
2018
$763

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$603
Abbott Laboratories
$587
Novartis Pharmaceuticals Corporation
$529
SANOFI-AVENTIS U.S. LLC
$498
Janssen Pharmaceuticals, Inc
$398
AstraZeneca Pharmaceuticals LP
$388
Boston Scientific Corporation
$339
Astellas Pharma US Inc
$339
Alnylam Pharmaceuticals Inc.
$336
E.R. Squibb & Sons, L.L.C.
$330
Merck Sharp & Dohme LLC
$325
PFIZER INC.
$253
Amarin Pharma Inc.
$249
Boehringer Ingelheim Pharmaceuticals, Inc.
$213
Philips Electronics North America Corporation
$163
Braemar Manufacturing, LLC
$154
Esperion Therapeutics, Inc.
$145
Merck Sharp & Dohme Corporation
$144
BIOTRONIK INC.
$129
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$118
Actelion Pharmaceuticals US, Inc.
$100
Bayer HealthCare Pharmaceuticals Inc.
$95
Medtronic Vascular, Inc.
$89
Bayer Healthcare Pharmaceuticals Inc.
$80
Philips North America LLC
$54
BOSTON SCIENTIFIC CORPORATION
$33
CVRx, Inc.
$24
Inspire Medical Systems, Inc.
$23
Regeneron Healthcare Solutions, Inc.
$16
Novo Nordisk Inc
$12
Ethicon US, LLC
$12
Top 3 companies account for 25.4% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (5050) Ext Holter · (5050) Extended Holter · (7999) SRC Undivided · (CK7) Extended Holter · AMVUTTRA · BRILINTA · BYDUREON · Barostim Neo System · CAMZYOS · CRT-Ps · Cardiac Monitoring Suite · ClosureFast · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · FARXIGA · General - Therapies · INSPIRE · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LINX Reflux Management System · LOKELMA · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · MERLIN@HOME · MITRACLIP · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · PRADAXA · PRALUENT · Quadra Assura CRT Defibrillator · RESONATE EL ICD VR · Repatha · Reveal LINQ · TYRX · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $114 per 100 Medicare services performed
Looking for a cardiovascular disease in Sebring?
Compare cardiovascular diseases in the Sebring area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
10
Per 100K population
9.6
County median income
$55,581
Nearest hospital
HCA FLORIDA HIGHLANDS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Siracuse is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 16% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Siracuse experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Siracuse performed 1,012 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Siracuse receive payments from pharmaceutical companies?
Yes. Dr. Siracuse received a total of $6,781 from 31 companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Siracuse's costs compare to other cardiovascular diseases in Sebring?
Dr. Siracuse's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Siracuse) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →